VitaNova Life Sciences Corporation Cash and Restricted Cash
VitaNova Life Sciences Corporation (VNOV) had Cash and Restricted Cash of $1.60 million as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-09-14
- 2026-07-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.60M.
- 2026-04-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.60M.
- 2026-01-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.17M.
- 2025-10-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.26M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-07-31 | $1.60M 10-Q · filed 2026-09-14 | |
| 2026-04-30 | $1.60M 10-Q · filed 2026-09-14 | |
| 2026-01-31 | $1.17M 10-Q · filed 2026-03-16 | |
| 2025-10-31 | $1.26M 10-Q · filed 2025-12-15 | |
| 2025-07-31 | $1.05M 10-Q · filed 2026-09-14 | $1.05M 10-Q · filed 2025-09-12 |
| 2025-04-30 | $782.81K 10-Q · filed 2026-09-14 | |
| 2025-01-31 | $405.17K 10-Q · filed 2026-03-16 | |
| 2024-10-31 | $222.79K 10-Q · filed 2025-12-15 | |
| 2024-07-31 | $141.63K 10-Q · filed 2025-09-12 | |
| 2024-04-30 | $593.04K 10-K · filed 2026-07-29 | |
| 2024-01-31 | $808.36K 10-Q · filed 2025-03-17 | |
| 2023-10-31 | $0.00 10-Q · filed 2024-12-13 | |
| 2023-07-31 | $0.00 10-Q · filed 2024-09-10 | |
| 2023-04-30 | $8.73K 10-K · filed 2025-07-24 | |
| 2023-01-31 | $11.01K 10-Q · filed 2024-03-11 | |
| 2022-10-31 | $36.19K 10-Q · filed 2023-12-15 | |
| 2022-07-31 | $29.88K 10-Q · filed 2023-09-14 | |
| 2022-04-30 | $23.10K 10-K · filed 2024-07-29 | |
| 2022-01-31 | $36.94K 10-Q · filed 2023-02-16 | |
| 2021-10-31 | $31.69K 10-Q · filed 2022-11-14 | |
| 2021-07-31 | $0.00 10-Q · filed 2022-09-01 | |
| 2021-04-30 | $0.00 10-K · filed 2023-05-15 | |
| 2020-04-30 | $0.00 10-K · filed 2022-05-16 |